Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanesMaryam B. Lustberg, Charles L. Shapiro, M. Guillaume Wientjes et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 28
Phase II study of low dose suramin as a sensitizer of paclitaxel/carboplatin (P/C) in non small cell lung cancer (NSCLC)Miguel A. Villalona‐Calero, Jessie L.‐S. Au, Teng‐Kuang Yeh et al.|Journal of Clinical Oncology|2004Cited by 2
Phase II study of low dose suramin as a sensitizer of paclitaxel/carboplatin (P/C) in non small cell lung cancer (NSCLC)Miguel A. Villalona‐Calero, Jessie L.‐S. Au, Gregory A. Otterson et al.|Journal of Clinical Oncology|2004Cited by 1